{"status": "ok", "totalResults": 3, "articles": [{"source": {"id": "ars-technica", "name": "Ars Technica"}, "author": "Samuel Axon", "title": "Anno 117 Pax Romana hands-on: Gorgeous, deep, and tricky to learn - Ars Technica", "description": "After a return to form in Anno 1800, 117 aims to seize an even bigger audience.", "url": "https://arstechnica.com/gaming/2025/05/anno-117-pax-romana-hands-on-deep-city-building-in-a-gorgeous-ancient-rome/", "urlToImage": "https://cdn.arstechnica.net/wp-content/uploads/2025/05/Anno-117-farms-1152x648-1747428860.jpg", "publishedAt": "2025-05-19T16:00:18Z", "content": null}, {"source": {"id": "techcrunch", "name": "TechCrunch"}, "author": "Kyle Wiggers", "title": "AI dev tools for Windows get a fresh coat of paint - TechCrunch", "description": "Microsoft wants to make it easier for developers to build AI-powered apps on Windows devices, so it's introducing a new suite of dev tools.", "url": "https://techcrunch.com/2025/05/19/microsoft-gives-its-ai-dev-tools-for-windows-a-fresh-coat-of-paint/", "urlToImage": "https://techcrunch.com/wp-content/uploads/2022/06/moshed-windows-11.jpg?resize=1200,752", "publishedAt": "2025-05-19T16:00:00Z", "content": "Microsoft wants to make it easier for developers to build AI-powered apps on Windows devices.\r\nOn Monday during its Build 2025 conference, Microsoft announced Windows AI Foundry, a rebranding and exp\u2026 [+2115 chars]"}, {"source": {"id": "techcrunch", "name": "TechCrunch"}, "author": "Zack Whittaker", "title": "Pharma giant Regeneron to buy 23andMe and its customers\u2019 data for $256M - TechCrunch", "description": "23andMe was sold by bankruptcy auction, a year after the company had a massive data breach.", "url": "https://techcrunch.com/2025/05/19/pharma-giant-regeneron-to-buy-23andme-and-its-customers-data-for-256m/", "urlToImage": "https://techcrunch.com/wp-content/uploads/2024/01/23-and-me-logo-and-box.jpg?resize=1200,800", "publishedAt": "2025-05-19T14:35:59Z", "content": "Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction.\u00a0\r\nRegeneron said it will acquire 23andMe\u2019s genomics servic\u2026 [+1173 chars]"}]}